Our data demonstrate that miR-34 restoration can overcome chemo-/radioresistance of the pancreatic cancer cells that have high levels of Bcl-2 and low basal levels of miR-34s, and are dependent on Bcl-2 for survival and resistance to therapy. The gene discussed is BCL2; the disease is familial pancreatic carcinoma.